Created at Source Raw Value Validated value
Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: subject (≥18 years old) or legally authorized representative provides informed consent prior to initiation of any study procedures. subject (or legally authorized representative) understands and agrees to comply with planned study procedures. male or non-pregnant female adult ≥18 years of age at time of enrolment. patient should be hospitalized has a confirmed diagnosis of sars-cov-2 infection, defined as either: laboratory-confirmed sars-cov-2 infection as determined by pcr, or other commercial or public health assay in any specimen as diagnosed within 60 hours prior to randomization or the combination of upper or lower respiratory infection symptoms (fever, cough, dyspnea, desaturation) and typical findings on chest ct scan and absence of other plausible diagnoses illness of any duration, and at least one of the following: radiographic infiltrates by imaging (chest x-ray, ct scan, etc.), or clinical assessment (evidence of rales/crackles on exam) and spo2 ≤ 94% on room air, or requiring supplemental oxygen. abo d typing of the patient should be done at least once and the result should be known.

inclusion criteria: subject (≥18 years old) or legally authorized representative provides informed consent prior to initiation of any study procedures. subject (or legally authorized representative) understands and agrees to comply with planned study procedures. male or non-pregnant female adult ≥18 years of age at time of enrolment. patient should be hospitalized has a confirmed diagnosis of sars-cov-2 infection, defined as either: laboratory-confirmed sars-cov-2 infection as determined by pcr, or other commercial or public health assay in any specimen as diagnosed within 60 hours prior to randomization or the combination of upper or lower respiratory infection symptoms (fever, cough, dyspnea, desaturation) and typical findings on chest ct scan and absence of other plausible diagnoses illness of any duration, and at least one of the following: radiographic infiltrates by imaging (chest x-ray, ct scan, etc.), or clinical assessment (evidence of rales/crackles on exam) and spo2 ≤ 94% on room air, or requiring supplemental oxygen. abo d typing of the patient should be done at least once and the result should be known.

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: 1. subject (≥18 years old) or legally authorized representative provides informed consent prior to initiation of any study procedures. 2. subject (or legally authorized representative) understands and agrees to comply with planned study procedures. 3. male or non-pregnant female adult ≥18 years of age at time of enrolment. 4. patient should be hospitalized 5. has a confirmed diagnosis of sars-cov-2 infection, defined as either: 1. laboratory-confirmed sars-cov-2 infection as determined by pcr, or other commercial or public health assay in any specimen as diagnosed within 60 hours prior to randomization or 2. the combination of upper or lower respiratory infection symptoms (fever, cough, dyspnea, desaturation) and typical findings on chest ct scan and absence of other plausible diagnoses 6. illness of any duration, and at least one of the following: 1. radiographic infiltrates by imaging (chest x-ray, ct scan, etc.), or 2. clinical assessment (evidence of rales/crackles on exam) and spo2 ≤ 94% on room air, or 3. requiring supplemental oxygen. 7. abo d typing of the patient should be done at least once and the result should be known.

inclusion criteria: 1. subject (≥18 years old) or legally authorized representative provides informed consent prior to initiation of any study procedures. 2. subject (or legally authorized representative) understands and agrees to comply with planned study procedures. 3. male or non-pregnant female adult ≥18 years of age at time of enrolment. 4. patient should be hospitalized 5. has a confirmed diagnosis of sars-cov-2 infection, defined as either: 1. laboratory-confirmed sars-cov-2 infection as determined by pcr, or other commercial or public health assay in any specimen as diagnosed within 60 hours prior to randomization or 2. the combination of upper or lower respiratory infection symptoms (fever, cough, dyspnea, desaturation) and typical findings on chest ct scan and absence of other plausible diagnoses 6. illness of any duration, and at least one of the following: 1. radiographic infiltrates by imaging (chest x-ray, ct scan, etc.), or 2. clinical assessment (evidence of rales/crackles on exam) and spo2 ≤ 94% on room air, or 3. requiring supplemental oxygen. 7. abo d typing of the patient should be done at least once and the result should be known.